Found: 63
Select item for more details and to access through your institution.
Role of PSMA-ligands imaging in Renal Cell Carcinoma management: current status and future perspectives.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2022, v. 148, n. 6, p. 1299, doi. 10.1007/s00432-022-03958-7
- By:
- Publication type:
- Article
Lutathera ® Orphans: State of the Art and Future Application of Radioligand Therapy with 177 Lu-DOTATATE.
- Published in:
- Pharmaceutics, 2023, v. 15, n. 4, p. 1110, doi. 10.3390/pharmaceutics15041110
- By:
- Publication type:
- Article
Glucose Metabolism Modification Induced by Radioligand Therapy with [ 177 Lu]Lu/[ 90 Y]Y-DOTATOC in Advanced Neuroendocrine Neoplasms: A Prospective Pilot Study within FENET-2016 Trial.
- Published in:
- Pharmaceutics, 2022, v. 14, n. 10, p. N.PAG, doi. 10.3390/pharmaceutics14102009
- By:
- Publication type:
- Article
90 Y/ 177 Lu-DOTATOC: From Preclinical Studies to Application in Humans.
- Published in:
- Pharmaceutics, 2021, v. 13, n. 9, p. 1463, doi. 10.3390/pharmaceutics13091463
- By:
- Publication type:
- Article
Misinterpretation of an inflammatory FDG uptake in a patient treated for Hodgkin lymphoma: a case report.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Treatment with the Radiolabelled Somatostatin Analog Lu-DOTATATE for Advanced Pancreatic Neuroendocrine Tumors.
- Published in:
- Neuroendocrinology, 2013, v. 97, n. 4, p. 347, doi. 10.1159/000348394
- By:
- Publication type:
- Article
PSMA PET/CT in Castration-Resistant Prostate Cancer: Myth or Reality?
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 22, p. 7130, doi. 10.3390/jcm12227130
- By:
- Publication type:
- Article
Comparison of MRI vs. [ 18 F]FDG PET/CT for Treatment Response Evaluation of Primary Breast Cancer after Neoadjuvant Chemotherapy: Literature Review and Future Perspectives.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 16, p. 5355, doi. 10.3390/jcm12165355
- By:
- Publication type:
- Article
Validation of 99mTc and 177Lu quantification parameters for a Monte Carlo modelled gamma camera.
- Published in:
- EJNMMI Physics, 2023, v. 10, n. 1, p. 1, doi. 10.1186/s40658-023-00547-6
- By:
- Publication type:
- Article
Efficacy of Lutetium-Peptide Receptor Radionuclide Therapy in Inducing Prolonged Tumour Regression in Small-Bowel Neuroendocrine Tumours: A Case of Favourable Response to Retreatment after Initial Objective Response.
- Published in:
- Oncology Research & Treatment, 2021, v. 44, n. 5, p. 276, doi. 10.1159/000515859
- By:
- Publication type:
- Article
18 F-FDG PET-Derived Volume-Based Parameters to Predict Disease-Free Survival in Patients with Grade III Breast Cancer of Different Molecular Subtypes Candidates to Neoadjuvant Chemotherapy.
- Published in:
- Cancers, 2023, v. 15, n. 10, p. 2715, doi. 10.3390/cancers15102715
- By:
- Publication type:
- Article
The Role of Molecular Imaging in Patients with Brain Metastases: A Literature Review.
- Published in:
- Cancers, 2023, v. 15, n. 7, p. 2184, doi. 10.3390/cancers15072184
- By:
- Publication type:
- Article
ITA-IMMUNO-PET: The Role of [18F]FDG PET/CT for Assessing Response to Immunotherapy in Patients with Some Solid Tumors.
- Published in:
- Cancers, 2023, v. 15, n. 3, p. 878, doi. 10.3390/cancers15030878
- By:
- Publication type:
- Article
The Value of Semiquantitative Parameters Derived from 18 F-FDG PET/CT for Predicting Response to Neoadjuvant Chemotherapy in a Cohort of Patients with Different Molecular Subtypes of Breast Cancer.
- Published in:
- Cancers, 2022, v. 14, n. 23, p. 5869, doi. 10.3390/cancers14235869
- By:
- Publication type:
- Article
The Role of [ 68 Ga]PSMA PET/CT for Clinical Suspicion of Prostate Cancer in Patients with or without Previous Negative Biopsy: A Systematic Review.
- Published in:
- Cancers, 2022, v. 14, n. 20, p. 5036, doi. 10.3390/cancers14205036
- By:
- Publication type:
- Article
Clinical Management of Neuroendocrine Neoplasms in Clinical Practice: A Formal Consensus Exercise.
- Published in:
- Cancers, 2022, v. 14, n. 10, p. 2501, doi. 10.3390/cancers14102501
- By:
- Publication type:
- Article
Rhenium Radioisotopes for Medicine, a Focus on Production and Applications.
- Published in:
- Molecules, 2022, v. 27, n. 16, p. 5283, doi. 10.3390/molecules27165283
- By:
- Publication type:
- Article
Verification of Angular Response of Sky Quality Meter with Quasi-Punctual Light Sources.
- Published in:
- Sensors (14248220), 2021, v. 21, n. 22, p. 7544, doi. 10.3390/s21227544
- By:
- Publication type:
- Article
Redefining Human–Robot Symbiosis: a bio-inspired approach to collaborative assembly.
- Published in:
- International Journal of Advanced Manufacturing Technology, 2023, v. 128, n. 5/6, p. 2043, doi. 10.1007/s00170-023-11920-1
- By:
- Publication type:
- Article
Y-based PET and SPECT/CT imaging in locoregional brain treatment for high-grade gliomas: retrospective fusion with MRI.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2012, v. 39, n. 11, p. 1822, doi. 10.1007/s00259-012-2200-2
- By:
- Publication type:
- Article
Peptide receptor radionuclide therapy with Lu-DOTATATE: the IEO phase I-II study.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2011, v. 38, n. 12, p. 2125, doi. 10.1007/s00259-011-1902-1
- By:
- Publication type:
- Article
Peptide receptor radionuclide therapy with <sup>90</sup>Y-DOTATOC in recurrent meningioma.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2009, v. 36, n. 9, p. 1407, doi. 10.1007/s00259-009-1115-z
- By:
- Publication type:
- Article
Radioembolisation with <sup>90</sup>Y-microspheres: dosimetric and radiobiological investigation for multi-cycle treatment.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2008, v. 35, n. 11, p. 2088, doi. 10.1007/s00259-008-0857-3
- By:
- Publication type:
- Article
Long-term evaluation of renal toxicity after peptide receptor radionuclide therapy with <sup>90</sup>Y-DOTATOC and <sup>177</sup>Lu-DOTATATE: the role of associated risk factors.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2008, v. 35, n. 10, p. 1847, doi. 10.1007/s00259-008-0778-1
- By:
- Publication type:
- Article
Long-term evaluation of renal toxicity after peptide receptor radionuclide therapy with <sup>90</sup>Y-DOTATOC and <sup>177</sup>Lu-DOTATATE: the role of associated risk factors.
- Published in:
- 2008
- By:
- Publication type:
- Correction Notice
Radiation protection in radionuclide therapies with <sup>90</sup>Y-conjugates: risks and safety.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2006, v. 33, n. 11, p. 1321, doi. 10.1007/s00259-006-0151-1
- By:
- Publication type:
- Article
Receptor radionuclide therapy with <sup>90</sup>Y-[DOTA]<sup>0</sup>-Tyr<sup>3</sup>-octreotide (<sup>90</sup>Y-DOTATOC) in neuroendocrine tumours.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2004, v. 31, n. 7, p. 1038, doi. 10.1007/s00259-004-1571-4
- By:
- Publication type:
- Article
Receptor-mediated radionuclide therapy with [sup 90] Y-DOTATOC in association with amino acid infusion: a phase I study.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2003, v. 30, n. 2, p. 207, doi. 10.1007/s00259-002-1023-y
- By:
- Publication type:
- Article
Uncommon solitary nasal extramedullary plasmacytoma detected by <sup>18</sup>F-FDG PET/CT.
- Published in:
- Hellenic Journal of Nuclear Medicine, 2021, v. 24, n. 3, p. 265
- By:
- Publication type:
- Article
Is There a Role for FAPI PET in Urological Cancers?
- Published in:
- Molecular Diagnosis & Therapy, 2024, v. 28, n. 6, p. 721, doi. 10.1007/s40291-024-00735-9
- By:
- Publication type:
- Article
A Prospective Randomized Multicenter Study on the Impact of [<sup>18</sup>F]F-Choline PET/CT Versus Conventional Imaging for Staging Intermediate- to High-Risk Prostate Cancer.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 8, p. 1, doi. 10.2967/jnumed.123.267355
- By:
- Publication type:
- Article
A Prospective Randomized Multicenter Study on the Impact of [<sup>18</sup>F]F-Choline PET/CT Versus Conventional Imaging for Staging Intermediate- to High-Risk Prostate Cancer.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 7, p. 1013, doi. 10.2967/jnumed.123.267355
- By:
- Publication type:
- Article
Diagnostic contribution of contrast-enhanced CT as compared to unenhanced low-dose CT in PET/CT staging and treatment response assessment of <sup>18</sup>FDG-avid lymphomas: a prospective study.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.120.259242
- By:
- Publication type:
- Article
Diagnostic contribution of contrast-enhanced CT as compared to unenhanced low-dose CT in PET/CT staging and treatment response assessment of 18FDG-avid lymphomas: a prospective study Value of FDG-PET/CECT in avid lymphomas.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.120.259242
- By:
- Publication type:
- Article
Diagnostic contribution of contrast-enhanced CT as compared to unenhanced low-dose CT in PET/CT staging and treatment response assessment of 18FDG-avid lymphomas: a prospective study.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.120.259242
- By:
- Publication type:
- Article
Diagnostic contribution of contrast-enhanced CT as compared to unenhanced low-dose CT in PET/CT staging and treatment response assessment of <sup>18</sup>FDG-avid lymphomas: a prospective study.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.120.259242
- By:
- Publication type:
- Article
Diagnostic contribution of contrast-enhanced CT as compared to unenhanced low-dose CT in PET/CT staging and treatment response assessment of <sup>18</sup>FDG-avid lymphomas: a prospective study Value of FDG-PET/CECT in avid lymphomas.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 7, p. 1, doi. 10.2967/jnumed.120.259242
- By:
- Publication type:
- Article
Diagnostic contribution of contrast-enhanced CT as compared to unenhanced low-dose CT in PET/CT staging and treatment response assessment of 18FDG-avid lymphomas: a prospective study.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 6, p. 1, doi. 10.2967/jnumed.120.259242
- By:
- Publication type:
- Article
Diagnostic contribution of contrast-enhanced CT as compared to unenhanced low-dose CT in PET/CT staging and treatment response assessment of 18FDG-avid lymphomas: a prospective study.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 5, p. 1, doi. 10.2967/jnumed.120.259242
- By:
- Publication type:
- Article
Epidemiology of gastroenteropancreatic neuroendocrine neoplasms: a review and protocol presentation for bridging tumor registry data with the Italian association for neuroendocrine tumors (Itanet) national database.
- Published in:
- Endocrine (1355008X), 2024, v. 84, n. 1, p. 42, doi. 10.1007/s12020-023-03649-4
- By:
- Publication type:
- Article
Radioligand therapy (RLT) as neoadjuvant treatment for inoperable pancreatic neuroendocrine tumors: a literature review.
- Published in:
- Endocrine (1355008X), 2022, v. 78, n. 2, p. 255, doi. 10.1007/s12020-022-03170-0
- By:
- Publication type:
- Article
Prognostic Role of PSMA-Targeted Imaging in Metastatic Castration-Resistant Prostate Cancer: An Overview.
- Published in:
- Biomedicines, 2024, v. 12, n. 10, p. 2355, doi. 10.3390/biomedicines12102355
- By:
- Publication type:
- Article
The Role of [ 18 F]F-Choline PET/CT in the Initial Management and Outcome Prediction of Prostate Cancer: A Real-World Experience from a Multidisciplinary Approach.
- Published in:
- Biomedicines, 2022, v. 10, n. 10, p. N.PAG, doi. 10.3390/biomedicines10102463
- By:
- Publication type:
- Article
ML Models Built Using Clinical Parameters and Radiomic Features Extracted from 18 F-Choline PET/CT for the Prediction of Biochemical Recurrence after Metastasis-Directed Therapy in Patients with Oligometastatic Prostate Cancer.
- Published in:
- Diagnostics (2075-4418), 2024, v. 14, n. 12, p. 1264, doi. 10.3390/diagnostics14121264
- By:
- Publication type:
- Article
Relevance of Volumetric Parameters Applied to [ 68 Ga]Ga-DOTATOC PET/CT in NET Patients Treated with PRRT.
- Published in:
- Diagnostics (2075-4418), 2023, v. 13, n. 4, p. 606, doi. 10.3390/diagnostics13040606
- By:
- Publication type:
- Article
Right Atrium Mass Assessed with 18F-FDG PET/CT Scan Turns Out to Be an Uncommon Relapse of Testicular Diffuse Large B-cell Lymphoma: A Case Report.
- Published in:
- Diagnostics (2075-4418), 2020, v. 10, n. 11, p. 987, doi. 10.3390/diagnostics10110987
- By:
- Publication type:
- Article
High activity <sup>90</sup>Y-ibritumomab tiuxetan (Zevalin<sup>®</sup>) with peripheral blood progenitor cells support in patients with refractory/resistant B-cell non-Hodgkin lymphomas.
- Published in:
- British Journal of Haematology, 2007, v. 139, n. 4, p. 590, doi. 10.1111/j.1365-2141.2007.06869.x
- By:
- Publication type:
- Article
Histopathological and Immunophenotypic Changes of Pancreatic Neuroendocrine Tumors after Neoadjuvant Peptide Receptor Radionuclide Therapy (PRRT).
- Published in:
- Endocrine Pathology, 2020, v. 31, n. 2, p. 119, doi. 10.1007/s12022-020-09623-4
- By:
- Publication type:
- Article
Somatostatin receptors imaging and therapy in a patient affected by esthesioneuroblastoma with meningeal metastases. A classic example of theranostic approach.
- Published in:
- 2016
- By:
- Publication type:
- Letter
Radioguided sentinel lymph node biopsy in patients with malignant cutaneous melanoma: The nuclear medicine contribution.
- Published in:
- Journal of Surgical Oncology, 2004, v. 85, n. 3, p. 141, doi. 10.1002/jso.20027
- By:
- Publication type:
- Article